ZARVY

Alzil-M Forte is a fixed-dose combination tablet that contains donepezil 10mg and memantine 10mg, specifically formulated for the management of moderate to severe Alzheimer's disease. This dual-ingredient approach integrates two pharmacological mechanisms—enhancing cholinergic function and mitigating excitotoxic neuronal damage—to provide comprehensive cognitive and behavioral support. Donepezil acts by inhibiting acetylcholinesterase, thereby maintaining acetylcholine levels essential for memory, attention, and learning. Memantine, an NMDA receptor antagonist, modulates excessive glutamate activity to prevent overstimulation and neurodegeneration. Together, they form a synergistic regimen that targets the complex pathology of Alzheimer’s. Alzil-M Forte offers significant improvements in mental clarity, daily functioning, and emotional stability. It is particularly effective in patients who have already responded well to individual therapy and require long-term, simplified dosing to maintain therapeutic continuity and compliance.

Zarcetam 800 is a high-strength formulation of Piracetam 800mg, a well-established nootropic known for enhancing cognition, memory, and neuronal efficiency. It supports neurotransmission, increases cerebral oxygen utilization, and promotes optimal brain metabolism. Zarcetam is used across a wide range of neurological conditions, including cognitive decline, learning difficulties, and attention deficits. Its safety profile makes it suitable for both short-term symptom relief and long-term cognitive support.